uniQure N.V. QURE
23.87 USD +0.90 (+3.92%)
At closeNov 4, 2026, 6:09 AM EST
24.05 +0.18 +0.75%
Pre-market · Nov 4, 6:09 AM ET
22.87 Day range 24.09
8.73 52-week range 51.72
- YTD
- -0.25%
- 1 year
- -30.39%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 60.31 +152.7% upside
Now 23.87
- Target (low)
- 27.96
- Target (mean)
- 60.31
- Target (high)
- 91.44
Ratings (0m) 13 11 buy · 2 hold · 0 sell
- Strong buy1
- Buy10
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.81964 | -1.05 – -0.658 | -1.19 | +31.2% | 5.43M | +69.9% | 11 |
| Next quarter | -0.81145 | -1.40 – -0.267 | -0.47393 | -71.2% | 6.82M | +44.7% | 11 |
| Current year | -3.44 | -4.21 – -3.02 | -2.93 | -17.4% | 21.11M | +54.9% | 11 |
| Next year | -2.64 | -4.18 – -0.473 | -3.44 | +23.2% | 96.17M | +355.6% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Oct 2, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 30, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| Jul 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 29, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 25, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 18, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Jun 18, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jun 18, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jun 18, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 30, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Apr 20, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Mar 23, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Mar 11, 2026 | Mizuho | Upgrade | Neutral | Outperform |
| Mar 10, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 9, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 9, 2026 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Mar 9, 2026 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Mar 3, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Mar 3, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Mar 3, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 3, 2026 | Mizuho | Downgrade | Outperform | Neutral |
| Mar 2, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Mar 2, 2026 | Cantor Fitzgerald | Upgrade | Overweight | Neutral |
| Feb 24, 2026 | Wolfe Research | Initiated | — | Peer Perform |
| Feb 10, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 28, 2026 | Barclays | Initiated | — | Equal-Weight |